| 注册
首页|期刊导航|中国医学创新|对比美托洛尔单用和联合通心络治疗冠心病心力衰竭的临床效果

对比美托洛尔单用和联合通心络治疗冠心病心力衰竭的临床效果

樊琳

中国医学创新Issue(16):65-66,67,3.
中国医学创新Issue(16):65-66,67,3.DOI:10.3969/j.issn.1674-4985.2015.16.024

对比美托洛尔单用和联合通心络治疗冠心病心力衰竭的临床效果

Comparing the Clinical Effect of Using Metoprolol Alone and Combined with Tong Xinluo in the Treatment of Coronary Heart Disease with Heart Failure

樊琳1

作者信息

  • 1. 河南省南阳市第一人民医院 河南 南阳 473010
  • 折叠

摘要

Abstract

Objective:To study the clinical effect of adding Tong Xinluo on the basis of metoprolol for the coronary heart disease with heart failure.Method:96 patients who were admitted in our hospital in recent years for coronary heart disease with heart failure were selected.They were radomly divided into the observation group and the contrast group at random.The contrast group was treated with metoprolol alone.The observation group was added Tong Xinluo on the basic treatment of the contrast group.The promotion of cardiac function and the control effect of the clinical symptoms between the two groups were compared.Result:Two groups had no obvious differences on cardiac function before the treatment.But the cardiac function of the the observation group improved more obviously after the treatment (P<0.05).On the treatment effect,the efficient rate of the contrast group was 81.25%,but the observation group can achieve 95.83%.There was significant difference between the two groups (P<0.05).Conclusion:Coronary heart disease with heart failure patients can get better clinical efficacy when they use Tong Xinluo capsule on the basis of the conventional therapy.Their cardiac function improved ulteriorly.This method has promotion value.

关键词

冠心病/通心络/美托洛尔/心功能

Key words

Coronary heart disease/Tong Xinluo/Metoprolol/Cardiac function

引用本文复制引用

樊琳..对比美托洛尔单用和联合通心络治疗冠心病心力衰竭的临床效果[J].中国医学创新,2015,(16):65-66,67,3.

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文